Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / Common Stock par value $0.012 per share
-
Shares outstanding
-
41M
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
149K
-
Shares change
-
+31.6K
-
Total reported value, excl. options
-
$1.16M
-
Value change
-
+$276K
-
Number of buys
-
5
-
Number of sells
-
-4
-
Price
-
$7.78
Significant Holders of ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) as of Q2 2017
23 filings reported holding ORMP - ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share as of Q2 2017.
ORAMED PHARMACEUTICALS INC. - Common Stock par value $0.012 per share (ORMP) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 149K shares
of 41M outstanding shares and own 0.36% of the company stock.
Largest 10 shareholders include BARCLAYS PLC (29.9K shares), RENAISSANCE TECHNOLOGIES LLC (25.1K shares), PNC Financial Services Group, Inc. (21.2K shares), Virtu KCG Holdings LLC (16.1K shares), WELLS FARGO & COMPANY/MN (14.7K shares), MORGAN STANLEY (12.6K shares), ETF MANAGERS GROUP, LLC (8.84K shares), Cutler Group LP (4.9K shares), Sterling Investment Advisors, Ltd. (3.15K shares), and GROUP ONE TRADING, L.P. (2K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.